Best CLIA-Waived POCT Devices for Home Health Agencies

Point-of-care testing can bring important diagnostic information directly to patients in their homes. For home health agencies operating in the United States, CLIA-waived POCT devices for home health agencies can support faster clinical decisions without requiring every patient to travel to a laboratory or clinic.

But choosing a POCT device is not simply a matter of buying a small analyzer. Home health agencies need to consider CLIA requirements, intended use, specimen collection, analytical performance, quality control, operator training, connectivity, consumable costs, and the practical realities of testing in patients' homes.

The FDA's current CLIA database lists numerous waived test systems, including blood glucose monitoring systems, urine testing systems, HbA1c analyzers, infectious disease tests, and other point-of-care technologies. Agencies should verify the current waiver status of the exact test system before purchasing.

What Does CLIA-Waived Mean for Home Health Agencies?

CLIA, or the Clinical Laboratory Improvement Amendments, establishes federal quality requirements for laboratory testing performed on human specimens in the United States. A waived test is categorized as a test system that has been determined to be simple to perform and to have a low risk of an incorrect result when performed according to the manufacturer's instructions.

Importantly, CLIA-waived does not mean error-proof. A waived test still needs to be performed correctly. The agency should follow the manufacturer's instructions, maintain appropriate documentation, ensure staff are appropriately trained, and comply with applicable CLIA requirements.

The FDA explains that CLIA waiver can apply to test systems listed as waived in regulation, systems granted a waiver through the application process, and certain test systems cleared by the FDA for home use.

For home health agencies, this distinction is particularly important because a device can be convenient and easy to use without necessarily being appropriate for every professional testing environment.

1. Blood Glucose Meters: The Most Practical POCT Device for  Care

Blood glucose testing is probably the most obvious starting point when building a POCT program for home health services. Portable glucose meters require a small capillary blood specimen and can provide a result within seconds.

They can be useful when caring for patients with diabetes, patients receiving glucose-lowering medications, and patients who require regular glucose monitoring as part of their care plan.

The FDA CLIA database contains numerous waived glucose monitoring systems from different manufacturers. This gives agencies considerable choice when evaluating equipment.

One important consideration is the intended use of the particular glucose meter. A consumer blood glucose meter intended for personal home use should not automatically be assumed to be appropriate for professional use across multiple patients.

For a home health agency, factors such as infection prevention, data management, strip availability, quality control, sample requirements, and professional intended use should be evaluated before purchasing.

What Makes a Good Home Health Glucose Meter?

Small capillary blood sample requirement

Fast result generation

Simple operator workflow

Clear error messages

Affordable and readily available test strips

Quality control support

Result storage and connectivity

Appropriate professional intended use

For a home health agency, connectivity can be especially valuable. Electronic transmission of results can reduce transcription errors and make it easier for nurses and supervising clinicians to review patient data.

2. HbA1c Point-of-Care Analyzers

Blood glucose provides information about the patient's glucose level at the time of testing. HbA1c provides a longer-term view of glycemic control and can therefore be useful in selected home-based clinical services.

One of the best-known professional POCT HbA1c systems is the Abbott Afinion HbA1c. The FDA has listed the Afinion HbA1c system among devices that have received a CLIA waiver through the application process.

HbA1c POCT can be useful in settings where clinicians need a rapid assessment during a patient encounter. A home health organization considering HbA1c testing should, however, assess the operational requirements carefully.

The analyzer may be considerably more demanding in terms of cost, consumables, storage, quality control, operator competency, and maintenance than a basic glucose meter.

The agency should also establish a clear procedure for handling results that are unexpected, inconsistent with the clinical picture, or outside the reportable range of the device.

3. Urinalysis Devices and Test Strips

Urinalysis is another useful area for home-based POCT. Depending on the system, urine testing can provide information about parameters such as glucose, protein, blood, ketones, leukocytes, nitrite, pH, and specific gravity.

Simple reagent strips can be particularly practical for home visits because they require little equipment. More advanced urine analyzers can standardize strip reading and reduce subjective interpretation of reagent-pad colors.

The FDA CLIA database lists numerous waived urine reagent strip systems and urine analyzers.

For home health nurses, urinalysis may be useful as a screening tool in selected situations. However, a urine dipstick should not be treated as a substitute for a complete urinalysis or urine culture when clinical circumstances require additional investigation.

4. Point-of-Care Coagulation Testing

Coagulation testing can be valuable in selected home-based care programs, particularly for patients receiving anticoagulation therapy. Portable coagulation systems can provide rapid measurements close to the patient and may reduce the need for frequent travel to a laboratory.

One example is the Universal Biosensors Xprecia Prime Coagulation System, which appears in FDA CLIA waiver decision summaries.

However, coagulation POCT requires careful patient selection, appropriate specimen collection, operator competency, quality assurance, and clinical protocols. It should be introduced only when the agency has a clear workflow for interpreting and acting on results.

5. Infectious Disease POCT for Home Health Services

Rapid infectious disease testing is another expanding area of point-of-care diagnostics. Depending on the specific device and regulatory authorization, POCT systems can test for respiratory infections and other conditions.

FDA CLIA waiver decision summaries include systems such as the Quidel Sofia 2 SARS Antigen+ FIA, Abbott ID NOW COVID-19 2.0, and the BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel.

However, these instruments differ significantly in complexity, workflow, specimen requirements, cost, and intended use. A home health agency should not assume that every waived infectious disease system is practical for routine home visits.

For mobile services, factors such as instrument size, power requirements, specimen stability, environmental conditions, turnaround time, and availability of controls and cartridges can have a major effect on feasibility.

How to Choose the Best CLIA-Waived POCT Devices for Home Health Agencies

The best device is the one that solves a genuine clinical and operational problem. Before purchasing, create a simple evaluation framework that considers the entire testing process rather than the analyzer alone.

Confirm CLIA status: Verify the exact model, assay, specimen type, and intended use in the current FDA CLIA database.

Check the intended setting: Confirm that the device is appropriate for professional testing in the proposed environment.

Evaluate sample collection: Consider whether staff can consistently obtain and handle the required specimen during home visits.

Calculate total cost: Include instruments, cartridges, strips, controls, batteries, maintenance, connectivity, and staff training.

Review quality requirements: Establish procedures for QC, competency assessment, troubleshooting, and documentation.

Consider connectivity: Electronic transfer can improve traceability and reduce transcription errors.

Plan for supply interruptions: Ensure that reagents, strips, controls, and other consumables can be obtained reliably.

Another important consideration is infection prevention. A device used for multiple patients must have a clearly defined cleaning and disinfection procedure that follows the manufacturer's instructions. Reusable equipment should not become a source of cross-contamination during home visits.

Why Quality Management Still Matters for Waived Testing

One of the biggest misconceptions about CLIA-waived testing is that quality management is unnecessary because the test is categorized as simple.

In practice, waived testing can still produce incorrect results because of specimen collection problems, operator mistakes, environmental conditions, expired reagents, incorrect storage, equipment problems, or failure to follow the manufacturer's instructions.

A strong home health POCT program should therefore define who can perform each test, how competency is assessed, how quality control is handled, what happens when QC fails, how equipment is maintained, and how patient results are documented.

Staff should also know when a POCT result needs confirmation or further laboratory investigation. A point-of-care result should always be interpreted within the patient's clinical context.

Choosing POCT Equipment That Works in the Real World

The growing availability of CLIA-waived POCT devices gives home health agencies an opportunity to bring useful diagnostic information closer to patients. Blood glucose meters are among the most practical options, while HbA1c, urinalysis, coagulation, and selected infectious disease systems can provide additional capabilities for appropriately designed home-based services.

The most important consideration is not simply which analyzer has the most features. A device that works well in a controlled laboratory may be poorly suited to a nurse carrying equipment between patients' homes. Portability, battery life, environmental conditions, specimen handling, consumable availability, connectivity, cleaning requirements, and technical support can be just as important as analytical performance.

For home health agencies, the strongest POCT programs begin with the clinical need and work backward to the technology. Identify the tests your patients genuinely require, verify the regulatory status and intended use of each device, calculate the complete cost of ownership, and establish the quality processes needed to produce dependable results.

When these elements are properly aligned, point-of-care testing can become more than a convenience. It can help healthcare professionals make informed decisions during the patient encounter, reduce unnecessary delays, and extend the reach of diagnostic services into the home while maintaining the standards expected of professional healthcare.